During the past decade, Boston Children's Hospital, Brigham & Women's Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Boston Children's Hospital, Brigham & Women's Hospital" #1 sponsor was "Nicole Hamblett" with 3 trials, followed by "Amalia Magaret" with 1 trials sponsored, "Calithera Biosciences, Inc" with 1 trials sponsored, "Chris Goss" with 1 trials sponsored and "National Jewish Health" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston Children's Hospital, Brigham & Women's Hospital" #1 collaborator was "Cystic Fibrosis Foundation" with 6 trials as a collaborator, "University of Texas" with 2 trials as a collaborator, "Children's Hospital Colorado" with 1 trials as a collaborator, "Dartmouth-Hitchcock Medical Center" with 1 trials as a collaborator and "Emory University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Boston Children's Hospital, Brigham & Women's Hospital" are "Cystic Fibrosis" (7 trials), "Cystic Fibrosis in Children" (1 trials) and "Pregnancy Related" (1 trials). Many other conditions were trialed in "Boston Children's Hospital, Brigham & Women's Hospital" in a lesser frequency.

Most popular intervention types in "Boston Children's Hospital, Brigham & Women's Hospital" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CB-280" (1 trials), "Continuation of dornase alfa (dnase)" (1 trials), "Continuation of hypertonic saline (HS)" (1 trials), "Discontinuation of dornase alfa (dnase)" (1 trials) and "Discontinuation of hypertonic saline (HS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Boston Children's Hospital, Brigham & Women's Hospital" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Boston Children's Hospital, Brigham & Women's Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Boston Children's Hospital, Brigham & Women's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Boston Children's Hospital, Brigham & Women's Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".